A Clinical Study to Evaluate the Long-term Safety (12 Months) of the Combination of Aliskiren 300 mg and Hydrochlorothiazide 25 mg

Status:
Completed

Trial end date:
2006-02-01

Target enrollment:

Participant gender:

The purpose of this study is to collect the long-term (12 months) safety data on aliskiren 300 mg when taken in combination with HCTZ 25 mg.

Phase 3

Novartis

Hydrochlorothiazide